Is a drug holiday off bisphosphonate therapy a valid strategy in the management of osteoporosis?
The most commonly prescribed treatment for osteoporosis is bisphosphonate therapy eg. Alendronate and Zolendronic Acid (by infusion). It's a common practice to stop therapy after 5 years, and then monitor bone markers to see if the osteoporosis is continuing. This seems to have arisen as a result of atypical femoral fractures that occurred on bisphosphonate therapy possibly on the basis of accumulated microcracks.
But some patients need to continue steroids which leads to continuing bone loss off therapy.
What's the risk of an atypical fracture with continued treatment vs a fracture from ceasing anti-osteoporosis treatment?
1 Comments
Sorted by latest first Latest Oldest Best
Bisphosphonate drug holidays should be considered if the person has taken the drug for an extended period of time and have a reservoir built up in their bone. Secondary therapy should be considered during the holiday to maintain bone density.
Source :
Diab, D. L., & Watts, N. B. (2013). Bisphosphonate drug holiday: who, when and how long. Therapeutic advances in musculoskeletal disease, 5(3), 107–111. doi.org/10.1177/1759720X13477714
Terms of Use Privacy policy Contact About Cancellation policy © freshhoot.com2025 All Rights reserved.